First Injection of Ketamine Among Young Injection Drug Users (IDUs) in Three U.S. Cities
Overview
Authors
Affiliations
Ketamine, a dissociative anesthetic, has emerged as an increasingly common drug among subgroups of young injection drug users (IDUs) in cities across the United States. In-depth qualitative interviews were conducted with 213 young IDUs aged 16-28 years recruited in New York, New Orleans, and Los Angeles between 2004 and 2006. While some initiated injection drug use with ketamine, the drug was more frequently injected by IDUs with extensive polydrug using histories. IDUs initiating with ketamine commonly self-injected via an intramuscular mode of administration. The injection group provided crucial knowledge and material resources that enabled the injection event to occur, including ketamine, syringes, and injection skills. Injection paraphernalia was commonly shared during the first injection of ketamine, particularly vials of pharmaceutically-packaged liquid ketamine. Injection events infrequently occurred in a rave or club and more typically in a private home, which challenges ketamine's designation as a 'club' drug. The first injection of ketamine was a noteworthy event since it introduced a novel drug or new mode of administration to be further explored by some, or exposed others to a drug to be avoided in the future. Risk reduction messages directed towards young IDUs should be expanded to include ketamine.
Gicquelais R, Werb D, Marks C, Ziegler C, Mehta S, Genberg B Epidemiol Rev. 2020; 42(1):4-18.
PMID: 33024995 PMC: 7947591. DOI: 10.1093/epirev/mxaa008.
Guise A, Horyniak D, Melo J, McNeil R, Werb D Addiction. 2017; 112(12):2098-2111.
PMID: 28734128 PMC: 5673537. DOI: 10.1111/add.13957.
Li Y, Shen R, Wen G, Ding R, Du A, Zhou J Front Pharmacol. 2017; 8:139.
PMID: 28373844 PMC: 5357631. DOI: 10.3389/fphar.2017.00139.
Factors associated with being asked to initiate someone into injection drug use.
Bluthenthal R, Wenger L, Chu D, Lorvick J, Quinn B, Thing J Drug Alcohol Depend. 2015; 149:252-8.
PMID: 25735468 PMC: 5048683. DOI: 10.1016/j.drugalcdep.2015.02.011.
Silva K, Kecojevic A, Lankenau S J Drug Issues. 2014; 43(4):483-496.
PMID: 25477621 PMC: 4251706. DOI: 10.1177/0022042613491099.